Community Acquired Pneumonia (CAP) (DBCOND0037905)

Identifiers

Synonyms
Community-Acquired Pneumoniae / Community Acquired Pneumonia / Community Aquired Pneumonia / Pneumonia, Community-Acquired / Community-Acquired Pneumonia (CAP) / Community-Acquired Pneumonia / Community acquired pneumonia (disorder) / Pneumonia, unspecified organism / Lung inflammation / Pneumonia / Pneumonia (disorder) / Pneumonia NOS / Pulmonitis

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Amoxicillin
A penicillin derivative used for the treatment of infections caused by gram-positive bacteria, in particular streptococcal bacteria causing upper respiratory tract infections.
Azithromycin
A macrolide antibiotic used to treat a variety of bacterial infections.
Cefazolin
A broad-spectrum cephalosporin antibiotic mainly used for the treatment of skin bacterial infections and other moderate to severe bacterial infections in the lung, bone, joint, stomach, blood, heart valve, and urinary tract.
Cefdinir
A third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections.
Cefditoren
A broad-spectrum third-generation cephalosporin antibiotic typically used to treat bacterial infections of the skin and respiratory tract.
Cefixime
A third generation cephalosporin used to treat susceptible Gram-negative and Gram-positive bacterial infections.
Cefpodoxime
A third-generation cephalosporin antibiotic used in the treatment of various bacterial infections, including gonorrhea, community acquired pneumonia, and sinusitis.
Cefprozil
A cephalosporin antibiotic used in the treatment of various bacterial infections, such as pharyngitis, tonsillitis, otitis media, and uncomplicated skin infections.
Ceftobiprole
A broad spectrum 5th-generation cephalosporin antibacterial indicated for certain kinds of pneumonia, bacteremia, and skin and skin structure infections, including those caused by MRSA.
Ceftriaxone
A broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, such as in the respiratory tract, skin, soft tissue, and urinary tract.
Clarithromycin
A macrolide antibiotic used for the treatment of a wide variety of bacterial infections such as acute otitis, pharyngitis, tonsillitis, respiratory tract infections, uncomplicated skin infections, and helicobacter pylori infection.
Dirithromycin
An antibiotic used to treat a variety of respiratory, skin, and other infections.
Erythromycin
A macrolide antibiotic used to treat and prevent a variety of bacterial infections.
Gemifloxacin
A quinolone antibacterial agent used for the treatment of acute bacterial exacerbation of chronic bronchitis and mild to moderate community-acquired pneumonia caused by susceptible bacteria.
Moxifloxacin
A fluoroquinolone antibiotic used to treat various bacterial infections.
Ofloxacin
An antibacterial agent used for the treatment of bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract.
Oxacillin
A penicillin antibiotic used to treat a number of susceptible bacterial infections.
Phenoxymethylpenicillin
A penicillin antibiotic used to prevent and treat mild to moderately severe infections in the respiratory tract, skin, and soft tissues.
Piperacillin
A penicillin antibiotic combined with tazobactam to treat piperacillin-resistant, piperacillin/tazobactam­ susceptible, β-lactamase generating strains of several bacteria.
Sparfloxacin
A fluoroquinolone antibiotic used to treat bacterial respiratory infections and sinusitis.
Sulbactam
An beta-lactamase inhibitor antibiotic combined with other antibiotics to treat a variety of susceptible bacterial infections.
Teicoplanin
A glycopeptide antibiotic with a similar mechanism of action and spectrum of activity to vancomycin used to treat various infections caused by gram-positive bacteria.
Tigecycline
A glycylcycline antibiotic used to treat a number of susceptible bacterial infections.
Trovafloxacin
An antibiotic used to treat gonorrhea and chlamydia.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03400735
Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adultstreatment4unknown_status
NCT05848713
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumoniatreatment3recruiting
NCT05380193
Serotype Distribution in Hospitalized Adult with Pneumococcal Community Acquired Pneumonia in FranceNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05962606
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.No drug interventionstreatment2recruiting
NCT06294600
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)treatment3recruiting
NCT06114888
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel DiagnosticsNo drug interventionsdiagnosticNot Availablerecruiting
NCT06027593
Using Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship InterventionsNo drug interventionsotherNot Availablecompleted
NCT06272994
Swab Testing to Optimize Pneumonia Treatment with Empiric VancomycinNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT06202521
CX-4945 in Viral Community Acquired Pneumoniatreatment2recruiting
NCT06263881
Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired PneumoniaNo drug interventionstreatment3recruiting
NCT05114902
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04350502
Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural InfectionsotherNot Availablecompleted
NCT03315403
Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"No drug interventionsNot AvailableNot Availablecompleted
NCT00646490
Pleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural EffusionNo drug interventionsNot AvailableNot Availablecompleted
NCT00489021
Feasibility and Outcomes of Older Patients HospitalizationNo drug interventionssupportive_careNot Availableunknown_status
NCT06097117
Role of Multiplex PCR in CAPNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05785442
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumoniatreatment2completed
NCT05762328
Duration of Antibiotic Treatment in Community-acquired PneumoniaNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05726253
Supportive Treatment and Antibiotics for Mild Pediatric Pneumoniaother0completed
NCT05711017
The Effect of Huashibaidu Granule on Community-acquired Pneumonia in ChildrenNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT05114161
Promoting Optimal Treatment for Community-acquired Pneumonia in the Emergency Room (PIONEER)No drug interventionsdiagnosticNot Availablecompleted
NCT04779242
Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumoniatreatment3completed
NCT04662047
The Impact of Air Pollution on the Consumption of Antimicrobials in the General PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04505605
Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 PneumoniaNo drug interventionsNot AvailableNot Availableterminated
NCT04612413
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patientstreatment2active_not_recruiting
NCT04089787
Shortened Antibiotic Treatment of 5 Days in Community-Acquired PneumoniaNo drug interventionstreatment4recruiting
NCT04071041
Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.treatment3terminated
NCT03728816
Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03675178
Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumoniatreatment4unknown_status
NCT03609099
Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Responsetreatment4unknown_status
NCT04835818
Point-of-Care Multiplex for Adult Patients With Severe Community-acquired PneumoniaNo drug interventionsdiagnosticNot Availableunknown_status
NCT05568654
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired PneumoniaNo drug interventionsdiagnosticNot Availablerecruiting
NCT05903352
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired PneumoniaNo drug interventionstreatment3recruiting
NCT03411824
Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency MedicineNo drug interventionsNot AvailableNot Availablecompleted
NCT03322670
Description of Pneumococcal PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT02833259
Avoidable Readmissions For Patients Hospitalized With Community-Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT02913118
Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumoniasupportive_care4unknown_status
NCT02963142
A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT03233516
Trial of Respiratory Infections in Children for Enhanced DiagnosticsNo drug interventionsNot AvailableNot Availablecompleted
NCT02492425
A Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02600806
Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatientstreatment4unknown_status
NCT02604628
Increasing Community-acquired Pneumonia Protocol Adherence by Antibiotic StewardshipNo drug interventionstreatmentNot Availablecompleted
NCT02380352
Short-course Antimicrobial Therapy for Paediatric Respiratory Infectionstreatment4completed
NCT02224716
Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in HospitalsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02139163
Epidemiological Study on Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01963442
Short Duration Treatment of Non-severe Community Acquired Pneumoniatreatment2unknown_status
NCT01937832
A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumoniatreatment3unknown_status
NCT01166932
Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumoniatreatment4completed
NCT01018199
Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired PneumoniaNo drug interventionstreatmentNot Availablewithdrawn
NCT00973154
Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trialtreatment3completed
NCT00270517
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumoniatreatment2unknown_status
NCT06532409
Comparison of Efficacy of Oral Amoxicillin Versus Intravenous CeftriaxonetreatmentNot Availablenot_yet_recruiting
NCT06516601
Fulminant Severe CAP - an Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06229288
Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Wardtreatment3not_yet_recruiting
NCT06210282
The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General PracticeNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT06134492
Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BALtreatment3recruiting
NCT06087809
Improving Short Course Treatment for Common Pediatric InfectionsNo drug interventionstreatmentNot Availablecompleted
NCT06029933
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 YearsNot AvailableNot Availablerecruiting
NCT05826873
Discharge Stewardship in Children's HospitalsNo drug interventionsotherNot Availableenrolling_by_invitation
NCT05663905
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patientstreatment4completed
NCT05531149
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 PneumoniaNo drug interventionstreatment3recruiting
NCT05380869
POCT PCT in Outpatient LRTINo drug interventionsdiagnosticNot Availablecompleted
NCT05395702
Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired PneumoniatreatmentNot Availablecompleted
NCT05290454
mNGS -Guided Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT05002192
A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired PneumoniaNot AvailableNot Availableunknown_status
NCT05009485
A Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAPNo drug interventionstreatmentNot Availablewithdrawn
NCT04963764
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumoniaother0completed
NCT04652414
Corticosteroids in Community Acquired Pneumoniaother2withdrawn
NCT04210102
Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room AdultsNo drug interventionsdiagnosticNot Availableunknown_status
NCT04198571
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple CountriesNot AvailableNot Availablecompleted
NCT04166110
Antibiotic Therapy In Respiratory Tract InfectionsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04135183
Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity ScoreNo drug interventionstreatmentNot Availableunknown_status
NCT04047108
pedCAPNETZ - Community Acquired Pneumonia (CAP) in Childhood and AdolescenceNo drug interventionsNot AvailableNot Availableunknown_status
NCT04094636
Physical Training During Hospital Admission With Community-Acquired PneumoniaNo drug interventionstreatmentNot Availableunknown_status
NCT03795662
Surviving PneumoniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03774953
The Effect of Protein Supplement on Lean Body Mass in Patients With PneumoniaNo drug interventionstreatmentNot Availablecompleted
NCT03745664
Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)treatment3unknown_status
NCT04686331
Accuracy of Lung Injury Biomarkers in the Initial Investigation of Patients With Suspected PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT03696303
Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in GuatemalaNo drug interventionsNot AvailableNot Availablecompleted
NCT05624684
Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.No drug interventionsNot AvailableNot Availablecompleted
NCT05133752
Oral Nemonoxacin in Treating Elderly Patients With CAPtreatment4completed
NCT06295120
The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)treatment4recruiting
NCT04415827
Energy Supply in Athletes and Untrained Persons With Bronchopulmonary DiseasesNo drug interventionspreventionNot Availableunknown_status
NCT03146182
Biomarker Guided Antibiotic Treatment in Community-Acquired PneumoniaNo drug interventionstreatmentNot Availableunknown_status
NCT03475732
Pharmacokinetics of XueBiJing in Patients With SepsisNo drug interventionstreatmentNot Availablecompleted
NCT03452826
Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired PneumoniaNo drug interventionsotherNot Availablecompleted
NCT03379207
Innate Immune Response During Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03360851
DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired PneumoniaNo drug interventionsdiagnosticNot Availableterminated
NCT03280004
Reason Evaluation of Initial Treatment Failure in Patients With CAPNot AvailableNot Availableunknown_status
NCT03256604
A Sputum Screening Test to Rule-out Pneumonia at an Early StageNo drug interventionsNot AvailableNot Availablecompleted
NCT02880384
Pathogen Detection and Community Acquired PneumoniaNo drug interventionsdiagnosticNot Availablecompleted
NCT02922387
Smoking Cessation Intervention in Respiratory Inpatientstreatment4completed
NCT02813694
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumoniatreatment3completed
NCT02523885
Use of Non Steroidal Antiinflammatory Drugs in Patients With Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT02668237
Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAPNo drug interventionsdiagnosticNot Availablecompleted
NCT02555852
Proton Pump Inhibitors and Risk of Community-acquired PneumoniaNot AvailableNot Availablecompleted
NCT02552342
Corticosteroid Therapy for Severe Community-Acquired Pneumoniatreatment4unknown_status
NCT02559310
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumoniatreatment3completed
NCT02454114
HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract InfectionsNo drug interventionssupportive_careNot Availablecompleted
NCT02489578
A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China)No drug interventionsNot AvailableNot Availableunknown_status
NCT02441855
Potential Role for Echocardiography in Adult Patients With Community-Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT02203110
The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02139384
Clinical Pediatric Pneumonia Score in Critically Ill ChildrenNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02107001
Lung Ultrasound in Pleuritic Chest PainNo drug interventionsNot AvailableNot Availablecompleted
NCT02018081
Pharmacokinetics of Levofloxacin in Intensive Care Unittreatment4completed
NCT01963000
Standardized Emergency Care for Community Acquired Pneumonia (CAP)No drug interventionsNot AvailableNot Availablecompleted
NCT01964495
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)No drug interventionstreatmentNot Availablecompleted
NCT01886053
A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumoniatreatment2completed
NCT01875731
Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal VaccineNo drug interventionsdiagnosticNot Availablecompleted
NCT01683487
Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.No drug interventionsNot AvailableNot Availablecompleted
NCT01651728
Effect of Simvastatin on Pneumonia Prognosis in Elderly Patientstreatment3unknown_status
NCT01660204
Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract InfectionsNo drug interventionstreatmentNot Availablecompleted
NCT01561885
Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through PathwaysNo drug interventionshealth_services_researchNot Availablecompleted
NCT01537250
Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)treatment2completed
NCT01420744
Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAPtreatment2completed
NCT01336036
Causes and Outcomes of Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT01285869
Impact of a Multidimensional Intervention in Elderly Patients With PneumoniaNo drug interventionssupportive_careNot Availablecompleted
NCT01236677
The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in BeijingNo drug interventionsNot AvailableNot Availableunknown_status
NCT01228110
Corticosteroids in Community Acquired PneumoneaNo drug interventionstreatmentNot Availablecompleted
NCT01200706
Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumoniatreatment4completed
NCT01108185
Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT01081964
Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumoniatreatment2terminated
NCT01071421
Sleep Apnea Syndrome and Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT01032694
Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired PneumoniaNot AvailableNot Availableterminated
NCT00929721
A Global Active Surveillance for Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00946166
Impact of Statins on Cytokine Expression in Pneumoniatreatment4withdrawn
NCT00908713
Corticoids in Severe Community-Acquired Pneumonia (CAP)treatment4completed
NCT00752947
Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factorstreatment4unknown_status
NCT00653172
Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired PneumoniaNo drug interventionstreatment2completed
NCT00523497
Efects of Noninvasive Mechanical Ventilation and Conventional Mechanical Ventilation in Patients With Severe Comunity PneumoniaNo drug interventionsNot AvailableNot Availableterminated
NCT00492271
First Time in Man Trial for Friulimicin Btreatment1terminated
NCT00258869
Observational Study of Sepsis and Pneumonia to Develop Diagnostic TestsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00079885
Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumoniatreatment3completed
NCT06577558
Efficacy and Safety of SR1375 in Adult Patients With CAPNo drug interventionstreatment2not_yet_recruiting
NCT06259110
Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06170372
High-dose Inhalations of Nitric Oxide in the Treatment of PneumoniatreatmentNot Availablerecruiting
NCT06065618
Characteristics of Hospitalized Patients With Community-acquired PneumoniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05722938
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)No drug interventionstreatment3recruiting
NCT05384314
A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05356494
Postural Drainage and PEP Technique in Community Acquired PneumoniaNo drug interventionstreatmentNot Availablecompleted
NCT04781829
Use of a Rapid Diagnostic Test for Antibiotic De-escalation in Severe Community Acquired PneumoniaNo drug interventionstreatmentNot Availablewithdrawn
NCT04724044
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumoniatreatment3completed
NCT04972318
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired PneumoniaNo drug interventionstreatmentNot Availableterminated
NCT04647630
Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary KitNo drug interventionsNot AvailableNot Availablerecruiting
NCT04540510
OPEP Devices in Acute Inpatient Treatment of PneumoniaNo drug interventionstreatmentNot Availableterminated
NCT06334874
Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.treatment4recruiting
NCT04160260
Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumoniatreatment1completed
NCT04158492
Impact of Comprehensive Molecular Tests on Antimicrobial Stewardship in Community-acquired PneumoniaNo drug interventionstreatmentNot Availableterminated
NCT04158310
Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in ChildrenNo drug interventionsNot AvailableNot Availableunknown_status
NCT03672994
Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless PatientNo drug interventionsNot AvailableNot Availablecompleted
NCT03212248
CRP and Thoracic Emergency Ultrasound in PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT04702074
TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAPNo drug interventionstreatmentNot Availableunknown_status
NCT04944719
Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.No drug interventionsNot AvailableNot Availableunknown_status
NCT05452226
Neuromuscular Electrical Stimulation in COPD/Community Acquired PneumoniaNo drug interventionstreatmentNot Availablerecruiting
NCT05606627
Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired PneumoniaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06279624
Effectiveness of the PCV13 in Older Thai AdultsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06291012
Stopping Pneumonia Antibiotherapy Regimen Earlytreatment4not_yet_recruiting
NCT03474991
KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAPtreatment3completed
NCT03466073
A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAPtreatment1 / 2completed
NCT06125340
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapytreatment4recruiting
NCT03098914
Clinical Characteristics and Microbiology of Community-Acquired PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02775968
Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired PneumoniaNot AvailableNot Availableunknown_status
NCT03031210
Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.treatment2 / 3recruiting
NCT02517489
Community-Acquired Pneumonia : Evaluation of Corticosteroidstreatment3completed
NCT02427048
Clinical Practice Guidelines and Impact of Audit and Feedback in the Emergency DepartmentNo drug interventionshealth_services_researchNot Availablecompleted
NCT02269644
A P3 Comparator Trial in Community Acquired Bacterial Pneumoniatreatment3withdrawn
NCT02205112
A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAPtreatment3completed
NCT01883869
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelortreatment1completed
NCT01787838
Improving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing SettingNo drug interventionshealth_services_researchNot Availablecompleted
NCT01773863
MACCE in Hospitalized Patients With Community-acquired PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01743755
Santeon-CAP; Dexamethasone in Community-acquired Pneumoniatreatment4terminated
NCT01723644
Clinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired PneumoniaNo drug interventionsotherNot Availablecompleted
NCT01662258
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAPNo drug interventionstreatmentNot Availablewithdrawn
NCT01661920
Suitability of Antibiotic Treatment for CAPNo drug interventionstreatmentNot Availablecompleted
NCT01631916
Corticosteroids in Community-acquired PneumoniaNo drug interventionstreatmentNot Availablewithdrawn
NCT01574066
Chest CT-scan for the Diagnosis of Community-acquired PneumoniaNo drug interventionsdiagnosticNot Availablecompleted
NCT01530763
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)treatment2 / 3completed
NCT01143155
Failure and Cardiovascular Events in Community-acquired PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00887276
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumoniatreatment4terminated
NCT00818610
Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumoniatreatment4completed
NCT00512772
Improved Use of Antibiotic Guidelines in Hospital EnvironmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00467701
Community Acquired Pneumonia in Telemark and OstfoldNo drug interventionsNot AvailableNot Availablecompleted
NCT00434291
Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumoniatreatment2completed
NCT00417326
Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired PneumoniaNo drug interventionstreatment2completed
NCT00390819
Epidemiology of Community Acquired Pneumonia in North IsraelNo drug interventionsNot AvailableNot Availableunknown_status
NCT00312741
Usefulness of Microbiological Tests in Community-Acquired PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00140023
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumoniatreatment3completed
NCT04043325
Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00308659
Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)No drug interventionsdiagnosticNot Availableunknown_status
NCT06601998
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00360295
A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adultstreatment3completed
NCT06605352
Clinical Impact of Rapid Molecular Testing for Pathogens in Patients With Severe Acute Respiratory Illness : A Pragmatic TrialNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01293435
Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin InfectionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00035347
Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumoniatreatment4completed
NCT03208361
Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.treatment3terminated
NCT04613375
PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and OlderNo drug interventionsNot AvailableNot Availablecompleted
NCT00809328
The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)treatment3completed
NCT00640926
Safety and Efficacy Study of Oxazolidinone to Treat Pneumoniatreatment2completed
NCT01130883
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SRNo drug interventionsNot AvailableNot Availablecompleted
NCT00546676
Ketek in CAP / AECB in Ambulatory Adult Patientstreatment4completed
NCT03439124
Ceftobiprole in the Treatment of Pediatric Patients With Pneumoniatreatment3completed
NCT05629741
A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101No drug interventionstreatment1terminated
NCT05657275
Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency RoomNo drug interventionsdiagnosticNot Availablecompleted
NCT06642701
Electrical Impedance Imaging Techniques in Guiding the Use of Chest Physiotherapy in Patients with PneumoniaNo drug interventionstreatmentNot Availablecompleted